BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36977195)

  • 1. KRAS mutations and endometriosis burden of disease.
    Orr NL; Albert A; Liu YD; Lum A; Hong J; Ionescu CL; Senz J; Nazeran TM; Lee AF; Noga H; Lawrenson K; Allaire C; Williams C; Bedaiwy MA; Anglesio MS; Yong PJ
    J Pathol Clin Res; 2023 Jul; 9(4):302-312. PubMed ID: 36977195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-Associated Mutations in Endometriosis without Cancer.
    Anglesio MS; Papadopoulos N; Ayhan A; Nazeran TM; Noë M; Horlings HM; Lum A; Jones S; Senz J; Seckin T; Ho J; Wu RC; Lac V; Ogawa H; Tessier-Cloutier B; Alhassan R; Wang A; Wang Y; Cohen JD; Wong F; Hasanovic A; Orr N; Zhang M; Popoli M; McMahon W; Wood LD; Mattox A; Allaire C; Segars J; Williams C; Tomasetti C; Boyd N; Kinzler KW; Gilks CB; Diaz L; Wang TL; Vogelstein B; Yong PJ; Huntsman DG; Shih IM
    N Engl J Med; 2017 May; 376(19):1835-1848. PubMed ID: 28489996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of KRAS, PPP2R1A and ARID1A mutations in 101 Chinese samples with ovarian endometriosis.
    Zou Y; Zhou JY; Guo JB; Wang LQ; Luo Y; Zhang ZY; Liu FY; Tan J; Wang F; Huang OP
    Mutat Res; 2018 May; 809():1-5. PubMed ID: 29547736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iatrogenic endometriosis harbors somatic cancer-driver mutations.
    Lac V; Verhoef L; Aguirre-Hernandez R; Nazeran TM; Tessier-Cloutier B; Praetorius T; Orr NL; Noga H; Lum A; Khattra J; Prentice LM; Co D; Köbel M; Mijatovic V; Lee AF; Pasternak J; Bleeker MC; Krämer B; Brucker SY; Kommoss F; Kommoss S; Horlings HM; Yong PJ; Huntsman DG; Anglesio MS
    Hum Reprod; 2019 Jan; 34(1):69-78. PubMed ID: 30428062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
    Sinicrope FA; Shi Q; Smyrk TC; Thibodeau SN; Dienstmann R; Guinney J; Bot BM; Tejpar S; Delorenzi M; Goldberg RM; Mahoney M; Sargent DJ; Alberts SR
    Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis.
    Stewart CJ; Leung Y; Walsh MD; Walters RJ; Young JP; Buchanan DD
    Hum Pathol; 2012 Aug; 43(8):1177-83. PubMed ID: 22305241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different mutation profiles between epithelium and stroma in endometriosis and normal endometrium.
    Suda K; Nakaoka H; Yoshihara K; Ishiguro T; Adachi S; Kase H; Motoyama T; Inoue I; Enomoto T
    Hum Reprod; 2019 Oct; 34(10):1899-1905. PubMed ID: 31621846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations.
    Inoue S; Hirota Y; Ueno T; Fukui Y; Yoshida E; Hayashi T; Kojima S; Takeyama R; Hashimoto T; Kiyono T; Ikemura M; Taguchi A; Tanaka T; Tanaka Y; Sakata S; Takeuchi K; Muraoka A; Osuka S; Saito T; Oda K; Osuga Y; Terao Y; Kawazu M; Mano H
    Nat Commun; 2019 Dec; 10(1):5785. PubMed ID: 31857578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility Outcomes After Laparoscopic Cystectomy in Infertile Patients with Stage III-IV Endometriosis: a Cohort with 6-10 years of Follow-up.
    Sun TT; Chen SK; Li XY; Zhang JJ; Dai Y; Shi JH; Jia SZ; Wu YS; Leng JH
    Adv Ther; 2020 May; 37(5):2159-2168. PubMed ID: 32200536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis suggests oligoclonality and metastasis of endometriosis lesions across anatomically defined subtypes.
    Praetorius TH; Leonova A; Lac V; Senz J; Tessier-Cloutier B; Nazeran TM; Köbel M; Grube M; Kraemer B; Yong PJ; Kommoss S; Anglesio MS
    Fertil Steril; 2022 Sep; 118(3):524-534. PubMed ID: 35715244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic pain in women with ovarian endometrioma is mostly associated with coexisting peritoneal lesions.
    Khan KN; Kitajima M; Fujishita A; Hiraki K; Matsumoto A; Nakashima M; Masuzaki H
    Hum Reprod; 2013 Jan; 28(1):109-18. PubMed ID: 23108348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of KRAS gene mutation and its clinical significance in colorectal adenocarcinoma].
    Xu C; Liu YL; Huang J; He DM; Hou YY; Ji Y; Hou J; Lu SH; Xu JF; Hu Q; Shi Y; Zhao LJ; Tan YS
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):667-70. PubMed ID: 23302307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials.
    Sinicrope FA; Shi Q; Allegra CJ; Smyrk TC; Thibodeau SN; Goldberg RM; Meyers JP; Pogue-Geile KL; Yothers G; Sargent DJ; Alberts SR
    JAMA Oncol; 2017 Apr; 3(4):472-480. PubMed ID: 28006055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with deep infiltrating endometriosis, adenomyosis and ovarian endometrioma.
    Yuan X; Wong BWX; Randhawa NK; Win TPP; Chan YH; Ma L; Yong EL
    Ann Acad Med Singap; 2023 Feb; 52(2):71-79. PubMed ID: 36880818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic Genomic Events in Endometriosis: Review of the Literature and Approach to Phenotyping.
    Yong PJ; Talhouk A; Anglesio MS
    Reprod Sci; 2021 Oct; 28(10):2743-2757. PubMed ID: 33469880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenomyosis pathogenesis: insights from next-generation sequencing.
    Bulun SE; Yildiz S; Adli M; Wei JJ
    Hum Reprod Update; 2021 Oct; 27(6):1086-1097. PubMed ID: 34131719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological significance of KRAS mutant allele expression in ovarian endometriosis.
    Yachida N; Yoshihara K; Suda K; Nakaoka H; Ueda H; Sugino K; Yamaguchi M; Mori Y; Yamawaki K; Tamura R; Ishiguro T; Kase H; Motoyama T; Enomoto T
    Cancer Sci; 2021 May; 112(5):2020-2032. PubMed ID: 33675098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapy.
    Cserepes M; Ostoros G; Lohinai Z; Raso E; Barbai T; Timar J; Rozsas A; Moldvay J; Kovalszky I; Fabian K; Gyulai M; Ghanim B; Laszlo V; Klikovits T; Hoda MA; Grusch M; Berger W; Klepetko W; Hegedus B; Dome B
    Eur J Cancer; 2014 Jul; 50(10):1819-1828. PubMed ID: 24768329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of Somatic Mutations in RAS/RAF/MAPK Signaling Pathway in Moroccan and North African Colorectal Cancer Patients.
    Benmokhtar S; Laraqui A; El Boukhrissi F; Hilali F; Bajjou T; Jafari M; El Zaitouni S; Baba W; El Mchichi B; Elannaz H; Lahlou IA; Chahdi H; Oukabli M; Mahfoud T; Tanz R; Ichou M; Ennibi K; Dakka N; Sekhsokh Y
    Asian Pac J Cancer Prev; 2022 Nov; 23(11):3725-3733. PubMed ID: 36444585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer.
    Nodin B; Zendehrokh N; Sundström M; Jirström K
    Diagn Pathol; 2013 Jun; 8():106. PubMed ID: 23800114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.